2016-04-28T15:45:42-05:00 2015-12-31 ERNST & YOUNG US LLP TWO NORTH CENTRAL AVENUE STE 2300 PHOENIX AZ 85004 990 2015-01-01 271120123 CREATIVE TESTING SOLUTIONS % SUSAN BARNES CREA 6023437016 6210 EAST OAK STREET SCOTTSDALE AZ 85257 SUSAN L BARNES EVP/CFO 4806755696 2016-04-21 true BRENDA GRIESEMER P00264669 4806755696 2015 2016-09-27 15:27:22Z SALLY CAGLIOTI 6210 EAST OAK STREET SCOTTSDALE AZ 85257 250223922 false X WWW.MYCTS.ORG X 2009 AZ TO PROVIDE EXCEPTIONAL CUSTOMIZED LABORATORY TESTING SERVICES TO SUPPORT THE HOSPITALS AND OTHER HEALTHCARE ORGANIZATIONS WITH THEIR LIFE SAVING MISSIONS. 11 9 465 5 260000 0 0 0 217463656 214954255 985834 11222263 0 0 218449490 226176518 1253275 1100594 0 0 38461312 35269136 0 0 0 163580670 167166544 203295257 203536274 15154233 22640244 90812035 94976211 23909281 26960990 66902754 68015221 X TO PROVIDE EXCEPTIONAL CUSTOMIZED LABORATORY TESTING SERVICES TO SUPPORT THE HOSPITALS AND OTHER HEALTHCARE ORGANIZATIONS WITH THEIR LIFE SAVING MISSIONS. false false 190113109 1100594 214045777 TESTING OF BLOOD SAMPLES RECEIVED FROM VOLUNTEER BLOOD DONORS PROVIDED IN CONJUNCTION WITH BLOOD DONATIONS AT NOT-FOR-PROFIT BLOOD CENTERS THROUGHOUT THE COUNTRY AS WELL AS HOSPITALS AND OTHER ORGANIZATIONS, AS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION. SEE SCHEDULE O FOR FURTHER DETAIL. 326675 0 908478 THE CTS RESEARCH PROGRAM IS DEDICATED TO ADVANCING BLOOD SAFETY AND EVIDENCE-BASED TRANSFUSION PRACTICES THROUGH SCIENTIFIC RESEARCH. SEE SCHEDULE O FOR FURTHER DETAIL. 190439784 true false false false false false false false false false true false false false false true true true false false false false false false false false false true false true false false false false false false true false false false false false false true true true false false true 25 0 true 465 true true true false false false false false X 11 9 false false false false true true true true true false false true true true true true false false false false AZ X SUSAN BARNES 4806755696 6210 E OAK STREET SCOTTSDALE AZ 85257 JAMES P AUBUCHON MD TRUSTEE 1.0 0.0 X 0 0 0 SUSAN BARNES TRUSTEE/CFO 10.0 40.0 X X 0 716067 21092 J DANIEL CONNOR TRUSTEE 2.0 38.0 X 0 672854 39344 JAMES P COVERT TRUSTEE 1.0 0.0 X 0 0 0 DONALD D DODDRIDGE TRUSTEE 2.0 0.0 X 0 0 0 WILLIAM G GREEN TRUSTEE/SECRETARY/TREASURER 1.0 4.0 X X 0 26500 0 KATHLEEN S PUSHOR TRUSTEE 1.0 3.0 X 0 23250 0 CHRIS STILES TRUSTEE/VICE CHAIR 1.0 0.0 X X 0 0 0 RON WAECKERLIN MD TRUSTEE 1.0 3.0 X 0 36000 0 RICK WALSH TRUSTEE 1.0 0.0 X 0 0 0 GARY K WILDE TRUSTEE/CHAIR 1.0 3.0 X X 0 25250 0 SALLY CAGLIOTI PRESIDENT 40.0 0.0 X 1089016 0 36623 EUGENE ROBERTSON PHD VICE PRESIDENT (thru 5/2015) 40.0 0.0 X 195212 0 34207 GERMAN LEPARC MD CHIEF MEDICAL OFFICER 20.0 0.0 X 203757 0 17023 BHAVI SHAH ASSISTANT SECRETARY 10.0 30.0 X 0 242326 24425 MARC PEARCE VICE PRESIDENT 40.0 0.0 X 283722 0 21234 PHILLIP WILLIAMSON PHD VICE PRESIDENT 40.0 0.0 X 295064 0 17618 NANCY L HAUBERT DIRECTOR 40.0 0.0 X 251275 0 21125 MICHAEL PHILLIPS DIRECTOR 40.0 0.0 X 245337 0 21842 JOAN DUNN-WILLIAMS DIRECTOR 40.0 0.0 X 239596 0 18713 SHERYL J CYRUS DIRECTOR 40.0 0.0 X 194530 0 21376 CHARLES MOREHEAD IT DIRECTOR (THRU 11/2015) 40.0 0.0 X 151143 0 17658 MORRIS DIXON DIRECTOR 0.0 0.0 X 187726 0 0 3336378 1742247 312280 38 true true true MEDIWARE INFORMATION SYSTEMS INC 11711 W 79TH STREET LENEXA KS 66214 INFO TECH CONSULTANT 712216 FEDEX PO BOX 94515 PALATINE IL 60094 DELIVERY SERVICE 604526 SOUTHWEST AIRLINES CARGO PO BOX 97390 DALLAS TX 75397 DELIVERY SERVICE 380321 MIDNITE EXPRESS DEPT 8255 LOS ANGELES CA 90084 DELIVERY SERVICE 326812 AMERICAN AIRLINES PO BOX 2994 CAROL STREAM IL 60133 DELIVERY SERVICE 285334 15 0 LABORATORY SERVICES 621500 213785777 213785777 RESEARCH & DEVELOPMENT SUPPORT 541700 908478 908478 LABORATORY MANAGEMENT SERVICE FEE 541611 260000 260000 214954255 794666 794666 0 0 0 0 0 34539714 -64713 24047404 10492310 -64713 10427597 10427597 0 0 0 0 226176518 214694255 260000 11222263 1100594 1100594 0 0 0 1667802 1667802 64824 64824 25723147 23363861 2359286 2669057 2347915 321142 3301561 2701066 600495 1842745 1638609 204136 848673 848673 35208 35208 14000 14000 0 0 15170 15170 276125 215733 60392 0 3658160 3623608 34552 893770 860735 33035 0 3408183 3145991 262192 436649 105660 330989 0 0 401 401 0 1024800 954713 70087 184223 48109 136114 OPERATING & TESTING SUPPLIES 145524349 145524349 EQUIP LEASES, REPAIRS & MAINT 4468344 4346226 122118 ALL OTHER EXPENSES 6378489 397791 5980698 203536274 190439784 13096490 0 23632757 19103408 32317650 32011699 0 0 28304813 34031089 0 0 0 0 0 0 4697523 1961027 561522 639390 25485818 18356220 1197770 7129598 0 0 0 0 0 0 0 0 100000 100000 90812035 94976211 23909281 26960990 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 23909281 26960990 X 66902754 68015221 0 0 0 0 66902754 68015221 90812035 94976211 X 22640244 -11527777 -10000000 X false true X true false X 0 1592248 755919 836329 0 21207649 16498198 4709451 0 2685921 1102103 1583818 7129598 0 0 X 214713454 -11527777 -11527777 226241231 -64713 -64713 226176518 203600987 64713 64713 203536274 203536274 Schedule D, Part X, Line 2 AT DECEMBER 31, 2015 AND 2014, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE THE TAX YEARS ENDED DECEMBER 31, 2012, THROUGH THE CURRENT TAX YEAR. AS OF DECEMBER 31, 2015 AND 2014, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2015. SCHEDULE D, PART XI, LINE 4B LOSS ON DISPOSAL OF ASSETS - RECLASSED FROM EXPENSES $(64,713) SCHEDULE D, PART XII, LINE 2D LOSS ON DISPOSAL OF ASSETS - RECLASSED TO REVENUE $64,713 true BLOOD SYSTEMS INC 6210 EAST OAK STREET SCOTTSDALE AZ 85257 860098929 501(C)(3) 1084804 TO BSRI FOR FURTHER RESEARCH 1 0 SCHEDULE I, PART I, LINE 2 CREATIVE TESTING SOLUTIONS RELIES ON BLOOD SYSTEMS, INC.'S GOOD GOVERNANCE AND OPERATIONAL PROCEDURES TO SPEND THE MONEY AS INTENDED. true true false false false false false true false SUSAN BARNES TRUSTEE/CFO 0 320595 0 0 0 395472 0 10600 0 10492 0 737159 0 384361 J DANIEL CONNOR TRUSTEE 0 660704 0 0 0 12150 0 28600 0 10744 0 712198 0 0 SALLY CAGLIOTI PRESIDENT 364615 0 96980 0 627421 0 28600 0 8023 0 1125639 0 616309 0 EUGENE ROBERTSON PHD VICE PRESIDENT (thru 5/2015) 122561 0 68220 0 4431 0 25689 0 8518 0 229419 0 0 0 GERMAN LEPARC MD CHIEF MEDICAL OFFICER 203757 0 0 0 0 0 0 0 17023 0 220780 0 0 0 BHAVI SHAH ASSISTANT SECRETARY 0 216214 0 15000 0 11112 0 10113 0 14312 0 266751 0 0 MARC PEARCE VICE PRESIDENT 213403 0 60350 0 9969 0 9710 0 11524 0 304956 0 0 0 PHILLIP WILLIAMSON PHD VICE PRESIDENT 225785 0 59310 0 9969 0 10600 0 7018 0 312682 0 0 0 NANCY L HAUBERT DIRECTOR 135444 0 38060 0 77771 0 8216 0 12909 0 272400 0 0 0 MICHAEL PHILLIPS DIRECTOR 195362 0 41050 0 8925 0 9801 0 12041 0 267179 0 0 0 JOAN DUNN-WILLIAMS DIRECTOR 184018 0 47790 0 7788 0 6124 0 12589 0 258309 0 0 0 SHERYL J CYRUS DIRECTOR 147972 0 38770 0 7788 0 7961 0 13415 0 215906 0 0 0 CHARLES MOREHEAD IT DIRECTOR (THRU 11/2015) 139563 0 11580 0 0 0 4602 0 13056 0 168801 0 0 0 MORRIS DIXON DIRECTOR 12507 0 0 0 175219 0 0 0 0 0 187726 0 0 0 SCHEDULE J, PART I, LINE 3 CREATIVE TESTING SOLUTIONS RELIES ON THE METHODS USED BY BLOOD SYSTEMS, INC. (BSI) IN ESTABLISHING COMPENSATION PAID TO THE PRESIDENT INCLUDING: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE OF CREATIVE TESTING SOLUTIONS. SCHEDULE J, PART I, LINE 4a MORRIS DIXON RECEIVED SEVERANCE PAYMENTs OF $175,219 DURING 2015. THIS AMOUNT IS TAXABLE AND IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2015 AS FOLLOWS: Sally Caglioti: $616,309 (RESULTING FROM ALMOST 27 YEARS OF SERVICE) SUSAN L. BARNES: $384,361 (RESULTING FROM ALMOST 26 YEARS OF SERVICE) THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN B(III) AND ALSO IN COLUMN F SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. Schedule J, Part I, Line 7 CREATIVE TESTING SOLUTIONS HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. SCHEDULE J, PART II NANCY HAUBERT AND MICHAEL PHILLIPS RECEIVED ONE-TIME PAYMENTS FOR RELOCATION EXPENSES. THIS AMOUNT IS TAXABLE AND IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(III). GERMAN LEPARC, MD IS PAID BY ONEBLOOD, A MINORITY MEMBER OF CREATIVE TESTING SOLUTIONS (CTS), AND SPLITS HIS TIME BETWEEN CTS AND ONEBLOOD. THE REPORTED AMOUNTS REPRESENT TOTAL COMPENSATION FOR SERVICES RENDERED TO BOTH ORGANIZATIONS. BHAVI SHAH RECIEVED A HIRING BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). MICHAEL LEPARC SON OF OFFICER 64824 EMPLOYEE COMPENSATION false FORM 990, PART III, LINES 4A AND 4B 4A) DONOR TESTING BLOOD DONOR TESTING SERVICES PROVIDED BY CREATIVE TESTING SOLUTIONS ("CTS") ARE ESSENTIAL TO ENSURING THE SAFETY OF THE NATION'S BLOOD SUPPLY. THESE TESTING ACTIVITIES ARE ABSOLUTELY NECESSARY AND MANDATED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION ("FDA") TO PROVIDE A SAFE BLOOD PRODUCT FOR TRANSFUSION TO PATIENTS. DUE TO THE SIGNIFICANT HEALTH RISKS ASSOCIATED WITH THE USE OF HUMAN BLOOD AND BLOOD COMPONENTS, IT IS CRITICAL FOR PUBLIC SAFETY PURPOSES THAT BLOOD BE PROPERLY TESTED BEFORE BEING INTRODUCED INTO THE HEALTHCARE SYSTEM FOR USE BY PATIENTS. A SAFE BLOOD SUPPLY IS CRITICAL TO THE WELL-BEING OF THE NATION'S HEALTHCARE SYSTEM AND ITS PATIENTS. THE SIGNIFICANCE OF THE TESTING OF BLOOD FOR PUBLIC SAFETY IS EVEN MORE PRONOUNCED IN THIS AGE OF THREATS FROM PANDEMICS AND TERRORISM. CREATIVE TESTING SOLUTIONS HAS THREE DONOR TESTING LABORATORIES (DTL). OUR FIRST ESTABLISHED LABORATORY IS IN TEMPE, ARIZONA. THE ADDITIONAL LABORATORIES ARE LOCATED IN BEDFORD, TEXAS AND ST. PETERSBURG, FLORIDA. THESE LOCATIONS ARE STRATEGICALLY POSITIONED NEAR MAJOR AIRPORTS IN PHOENIX, DALLAS AND TAMPA. ALL THREE DTL LABORATORIES ARE FOOD AND DRUG ADMINISTRATION (FDA) REGISTERED FACILITIES AND HOLD CURRENT CERTIFICATIONS FOR THE CLINICAL LABORATORY IMPROVEMENT ACT (CLIA) AS WELL AS ACCREDITATION WITH THE AMERICAN ASSOCIATION OF BLOOD BANKS (AABB), THE NEW YORK STATE DEPARTMENT OF HEALTH, CALIFORNIA DEPARTMENT OF HEALTH SERVICES AND STATE OF FLORIDA AGENCY FOR HEALTH CARE ADMINISTRATION. IN ADDITION TO DONOR SPECIMEN TESTING, THE LABORATORIES PARTICIPATE IN CLINICAL EVALUATION OF REAGENTS, TEST KITS, AND EQUIPMENT. CTS PROVIDES THE HIGHEST QUALITY IN TESTING AND SERVICE. THE LABORATORIES MAINTAIN INTERNAL QUALITY CONTROL PROGRAMS AND PARTICIPATE VOLUNTARILY IN EXTERNAL QUALITY CONTROL PROGRAMS. BLOOD SPECIMENS ARE PROCESSED UTILIZING STATE OF THE ART TECHNOLOGY WITH FDA LICENSED TEST KITS AND REAGENTS. ALL LABORATORIES ARE EQUIPPED WITH MULTIPLE AND REDUNDANT INSTRUMENTS REQUIRED FOR ROUTINE PROCESSING. ADDITIONALLY, EACH FACILITY ACTS AS A BACKUP LABORATORY TO THE OTHER CTS LABS. SPECIAL TESTING OUR SPECIAL TESTING LABORATORIES IN THE PHOENIX AND TAMPA AREAS PERFORM CONFIRMATORY AND SUPPLEMENTAL TESTING OF DONOR SAMPLES AS WELL AS NON-DONATION TESTING SUCH AS DONOR RE-ENTRY, POST EXPOSURE AND DONOR FOLLOW-UP. WE ALSO PROVIDE TESTING FOR EYE BANKS, TISSUE BANKS AND CORD BLOOD CENTERS. THE SPECIAL TESTING LABORATORY ALSO COMPLIES WITH CLIA, FDA, CA, NY, MD, AND FL STATE REGULATIONS. COMPONENT QUALITY CONTROL OUR COMPONENT QUALITY CONTROL LABORATORY IN PHOENIX PROVIDES BLOOD COMPONENT QUALITY CONTROL TESTING. RESIDUAL WHITE BLOOD CELL (RWBC) COUNTS ARE PERFORMED ON LEUKOREDUCED PRODUCTS. FACTOR VIII AND FIBRINOGEN ASSAYS ARE PERFORMED ON CRYOPRECIPITATE AND PLASMA PRODUCTS. BACTERIAL DETECTION IS PERFORMED ON APHERESIS PLATELETS. 4B) RESEARCH AND DEVELOPMENT THE CTS RESEARCH PROGRAM FOCUSES ON THE DEVELOPMENT AND/OR EVALUATION OF NEW BLOOD DONOR SCREENING TECHNOLOGIES WHICH SIGNIFICANTLY IMPROVE AND PROMOTE BLOOD SAFETY IN THE AREAS OF INFECTIOUS DISEASE, IMMUNOLOGY, MOLECULAR DIAGNOSTICS, AND EPIDEMIOLOGY. ADDITIONALLY, THE CTS RESEARCH PROGRAM SERVES AS THE FOCUS FOR A MULTI-INSTITUTIONAL CONSORTIUM WHICH INTEGRATES DATA FROM APPROXIMATELY 35% OF THE US BLOOD SUPPLY FOR THE PURPOSE OF DRIVING THE EVALUATION OF BEST PRACTICES IN TRANSFUSION MEDICINE, THE PROMOTION OF DONOR HEALTH, AND THE IMPROVEMENT OF TRANSFUSION RECIPIENT OUTCOMES. FORM 990, PART VI, LINE 6 CREATIVE TESTING SOLUTIONS HAS FOUR NONPROFIT CORPORATE MEMBERS: BLOOD SYSTEMS, INC. ("BSI"), THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITxM"), BLOODWORKS NORTHWEST (FKA PUGET SOUND, "BWNW") AND ONEBLOOD, INC. FORM 990, PART VI, LINE 7A THE BOARD OF DIRECTORS CONSISTS OF NO LESS THAN 11 AND NO MORE THAN 17 DIRECTORS APPOINTED BY THE MEMBERS (BSI, ITXM, ONEBLOOD, INC., AND BWNW). BSI SHALL BE ENTITLED TO DESIGNATE A MAJORITY OF THE NUMBER OF DIRECTORS AT ALL TIMES. FORM 990, PART VI, LINE 7B CERTAIN ACTIONS AND DECISIONS OF THE CORPORATION REQUIRE PRIOR UNANIMOUS APPROVAL FROM EACH OF THE FOUR MEMBERS (BSI, ITxM, BWNW, AND ONEBLOOD, INC.) PER THE BYLAWS. FORM 990, PART VI, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM BASED ON INFORMATION PROVIDED BY THE CFO AND THE FINANCE TEAM. A COPY OF THE DRAFT FORM 990 AND SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE BOARD AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING THE FORM 990 WITH THE IRS. FORM 990, PART VI, LINE 12C EACH YEAR, THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE DIRECTORS, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. FORM 990, PART VI, LINE 14 BLOOD SYSTEMS, INC. ("BSI") MAINTAINS THE RECORDS OF CREATIVE TESTING SOLUTIONS ("CTS"). SINCE CTS MAINTAINS NO RECORDS, IT HAS NOT ADOPTED A DOCUMENT RETENTION AND DESTRUCTION POLICY ITSELF. INSTEAD CTS RECORDS ARE MAINTAINED UNDER THE DOCUMENT RETENTION AND DESTRUCTION POLICY OF BSI. FORM 990, PART VI, LINE 15A AND 15B CREATIVE TESTING SOLUTION RELIES ON THE METHODS USED BY BSI IN ESTABLISHING COMPENSATION PAID TO THE PRESIDENT INCLUDING: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE OF CREATIVE TESTING SOLUTIONS. FORM 990, PART VI, LINE 19 THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE BLOOD SYSTEMS' WEBSITE. FORM 990, PART XI, LINE 9 DISTRIBUTION TO MEMBERS $(10,000,000) BLOOD SYSTEMS INC 6210 E OAK STREET SCOTTSDALE AZ 85257 860098929 BLOOD BANKING AZ 501(C)(3) 9 NA false INLAND NORTHWEST BLOOD CENTER 210 W CATALDO AVENUE SPOKANE WA 99201 910499130 BLOOD BANKING WA 501(C)(3) 9 BSI true BLOOD CENTERS OF THE PACIFIC 270 MASONIC AVENUE SAN FRANCISCO CA 94118 941156555 BLOOD BANKING CA 501(C)(3) 9 BSI true BELLE BONFILS MEMORIAL BLOOD CENTER 717 Yosemite STREET DENVER CO 80230 840411209 Blood Banking CO 501(C)(3) 9 BSI true BLOOD BANK OF SAN BERNARDINO & RIVERSIDE PO BOX 1429 SAN BERNARDINO CA 92402 951708743 BLOOD BANKING CA 501(C)(3) 9 BSI true MID-SOUTH REGIONAL BLOOD CENTER inc 1040 MADISON AVENUE MEMPHIS TN 38104 620719021 BLOOD BANKING TN 501(C)(3) 9 BSI true BERGEN COMMUNITY REGIONAL BLOOD CTR INC 102 CHESTNUT RIDGE ROAD MONTVALE NJ 07645 221541702 BLOOD BANKING NJ 501(C)(3) 9 BSI true LIFESHARE COMMUNITY BLOOD SERVICES 105 CLEVELAND STREET ELYRIA OH 44035 341163202 BLOOD BANKING OH 501(C)(3) 9 BSI true CANYON STATE INSURANCE COMPANY WEST BAY ROAD GRAND CAYMAN CJ 981084327 INVESTMENT CJ NA FOREIGN true false true false false false false false false false false true true true false false true false false false BLOOD CENTERS OF THE PACIFIC L 3231353 ACCRUAL INLAND NORTHWEST BLOOD CENTER L 2067029 ACCRUAL BELLE BONFILS MEMORIAL BLOOD CENTER L 6025443 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE L 5000477 ACCRUAL LIFESHARE COMMUNITY BLOOD SERVICES L 1388114 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER INC L 1955122 ACCRUAL MID-SOUTH REGIONAL BLOOD CENTER INC L 466138 ACCRUAL